Rtw Investments, LP Acadia Pharmaceuticals Inc Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rtw Investments, LP holds 8,540,117 shares of ACAD stock, worth $190 Million. This represents 2.32% of its overall portfolio holdings.
Number of Shares
8,540,117
Previous 8,705,501
1.9%
Holding current value
$190 Million
Previous $160 Million
11.2%
% of portfolio
2.32%
Previous 2.61%
Shares
10 transactions
Others Institutions Holding ACAD
# of Institutions
358Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$955 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$339 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$269 Million0.0% of portfolio
-
State Street Corp Boston, MA6.99MShares$156 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.68MShares$104 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.61B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...